Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy

Overview of attention for article published in Critical Care, December 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 19 X users

Citations

dimensions_citation: 76 Dimensions

Readers on

mendeley: 67 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 21 X posts from 19 X users, with an upper bound of 50,965 followers.

RT @PharmDStuuuu: What we know about the PK and effects of SBECD in kidney failure is from IV voriconazole literature, also uses SBECD. In…

08 Jan 2022

Reply Repost Favourite

What we know about the PK and effects of SBECD in kidney failure is from IV voriconazole literature, also uses SBECD. In short courses, remd and vori are generally well tolerated, w/o significant ADR noted despite documented accumulation of SBECD . https:/

08 Jan 2022

Reply Repost Favourite

@NNeanderMedical I checked that and risk was exaggerated, while removal could be easy. https://t.co/eYkMf6OavQ

27 Dec 2021

Reply Repost Favourite

@mrultiva https://t.co/jBxB5oodnU

29 Apr 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 17 additional X posts.